101 related articles for article (PubMed ID: 9696137)
1. Platelet activation and turnover in the primary antiphospholipid syndrome.
Joseph JE; Donohoe S; Harrison P; Mackie IJ; Machin SJ
Lupus; 1998; 7(5):333-40. PubMed ID: 9696137
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric detection of circulating activated platelets in primary antiphospholipid syndrome. Correlation with thrombocytopenia and anticardiolipin antibodies.
Fanelli A; Bergamini C; Rapi S; Caldini A; Spinelli A; Buggiani A; Emmi L
Lupus; 1997; 6(3):261-7. PubMed ID: 9104734
[TBL] [Abstract][Full Text] [Related]
3. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis.
Joseph JE; Harrison P; Mackie IJ; Isenberg DA; Machin SJ
Br J Haematol; 2001 Nov; 115(2):451-9. PubMed ID: 11703349
[TBL] [Abstract][Full Text] [Related]
4. Platelet activation markers and the primary antiphospholipid syndrome (PAPS).
Joseph JE; Harrison P; Mackie IJ; Machin SJ
Lupus; 1998; 7 Suppl 2():S48-51. PubMed ID: 9814673
[TBL] [Abstract][Full Text] [Related]
5. Possible pathogenetic role of activated platelets in the primary antiphospholipid syndrome involving the central nervous system.
Emmi L; Bergamini C; Spinelli A; Liotta F; Marchione T; Caldini A; Fanelli A; De Cristofaro MT; Dal Pozzo G
Ann N Y Acad Sci; 1997 Aug; 823():188-200. PubMed ID: 9292045
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome.
Patsouras MD; Sikara MP; Grika EP; Moutsopoulos HM; Tzioufas AG; Vlachoyiannopoulos PG
J Autoimmun; 2015 Dec; 65():30-7. PubMed ID: 26283469
[TBL] [Abstract][Full Text] [Related]
8. Platelet activation in patients with antiphospholipid syndrome.
Shechter Y; Tal Y; Greenberg A; Brenner B
Blood Coagul Fibrinolysis; 1998 Oct; 9(7):653-7. PubMed ID: 9863715
[TBL] [Abstract][Full Text] [Related]
9. Familial lupus anticoagulant.
Tănăseanu C; Tănăseanu S
Roum Arch Microbiol Immunol; 1999; 58(3-4):259-65. PubMed ID: 11845463
[TBL] [Abstract][Full Text] [Related]
10. Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events.
Levy Y; Shenkman B; Tamarin I; Pauzner R; Shoenfeld Y; Langevitz P; Savion N; Varon D
Arthritis Rheum; 2005 Dec; 52(12):4011-7. PubMed ID: 16320349
[TBL] [Abstract][Full Text] [Related]
11. Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome.
Bontadi A; Ruffatti A; Falcinelli E; Giannini S; Marturano A; Tonello M; Hoxha A; Pengo V; Punzi L; Momi S; Gresele P
Thromb Haemost; 2013 May; 109(5):901-8. PubMed ID: 23572134
[TBL] [Abstract][Full Text] [Related]
12. IgG from patients with antiphospholipid syndrome binds to platelets without induction of platelet activation.
Ford I; Urbaniak S; Greaves M
Br J Haematol; 1998 Aug; 102(3):841-9. PubMed ID: 9722315
[TBL] [Abstract][Full Text] [Related]
13. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Chung I; Choudhury A; Patel J; Lip GY
Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
[TBL] [Abstract][Full Text] [Related]
14. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
15. In vitro effect of anti-β₂ glycoprotein I antibodies on P-selectin expression, a marker of platelet activation.
Bontadi A; Ruffatti A; Giannini S; Falcinelli E; Tonello M; Hoxha A; Gresele P; Punzi L
Reumatismo; 2012 Mar; 64(1):35-9. PubMed ID: 22472781
[TBL] [Abstract][Full Text] [Related]
16. [Antiphospholipid-syndrome - when to treat?].
Specker Ch
Dtsch Med Wochenschr; 2012 Sep; 137(36):1748-50. PubMed ID: 22933198
[No Abstract] [Full Text] [Related]
17. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
[TBL] [Abstract][Full Text] [Related]
18. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
Larsen SB; Grove EL; Kristensen SD; Hvas AM
Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
[TBL] [Abstract][Full Text] [Related]
19. Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study.
Grau AJ; Reiners S; Lichy C; Buggle F; Ruf A
Stroke; 2003 Apr; 34(4):849-54. PubMed ID: 12637702
[TBL] [Abstract][Full Text] [Related]
20. Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function.
Gresele P; Migliacci R; Vedovati MC; Ruffatti A; Becattini C; Facco M; Guglielmini G; Boscaro E; Mezzasoma AM; Momi S; Pengo V
Thromb Res; 2009; 123(3):444-51. PubMed ID: 18617225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
